Shandong Runzhong Pharmaceutical

Shandong Runzhong Pharmaceutical is a specialized manufacturing subsidiary of Hansoh Pharmaceutical Group, one of China's largest and most innovative pharmaceutical companies. Based in Weifang, Shandong, the company operates as a primary production hub for Active Pharmaceutical Ingredients (APIs) and chemical intermediates that support Hansoh's extensive drug portfolio. The facility adheres to rigorous international quality standards, including GMP certifications, enabling the supply of critical components for therapies in oncology, infectious diseases, and metabolic disorders. By integrating advanced chemical synthesis and large-scale production capabilities, Shandong Runzhong plays a vital role in the parent company's vertical integration strategy and global commercialization efforts. The site is instrumental in the production of key marketed products such as almonertinib and flumatinib.